Physician

Philip Isaac Niles, MD

According to 2025 Medicare claims, Philip Niles, MD (NPI: 1609136126) practices ophthalmology in the Buffalo-Cheektowaga, NY market, with the plurality of this provider's patient population coming from Erie, NY. This provider's primary affiliated billing organization is OPHTHALMIC CONSULTANTS OF LONG ISLAND (NPI: 1285675660; TIN: 112498332) and primary practice location at 14221-7051.

Niles' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 778 traditional Medicare patients, billed 31,958 HCPCS/CPT codes, and received $1,930,655 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 809 prescription claims across 225 beneficiaries totaling $38,490 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 14 records totaling $6,707. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $124,136 to $1,930,655. Similarly, Part D prescription costs have risen steadily, from $37,625 to $38,490. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$965K$1.9M2017 Medicare payment: $124,136 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $351,535 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $595,775 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $957,474 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,338,149 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,825,005 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,592,862 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,930,655 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017141950$124,136
20183083,188$351,535
20194515,180$595,775
20205255,875$957,474
20217237,833$1,338,149
202273511,204$1,825,005
202362019,111$1,592,862
202477831,958$1,930,655

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$22K$43K2015 Drug cost: $37,625 (USD; Tot_Drug_Cst)2016 Drug cost: $22,726 (USD; Tot_Drug_Cst)2017 Drug cost: $10,302 (USD; Tot_Drug_Cst)2018 Drug cost: $22,263 (USD; Tot_Drug_Cst)2019 Drug cost: $35,994 (USD; Tot_Drug_Cst)2020 Drug cost: $38,159 (USD; Tot_Drug_Cst)2021 Drug cost: $40,947 (USD; Tot_Drug_Cst)2022 Drug cost: $43,367 (USD; Tot_Drug_Cst)2023 Drug cost: $40,101 (USD; Tot_Drug_Cst)2024 Drug cost: $38,490 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015128515$37,625
2016111363$22,726
201752122$10,302
2018116334$22,263
2019133481$35,994
2020162447$38,159
2021209613$40,947
2022208673$43,367
2023181651$40,101
2024225809$38,490

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye2921,533$97
92014Established patient complete exam of visual system6461,139$88
92012Established patient problem focused exam of visual system3651,054$64
92134Imaging of retina4561,661$30
92250Photography of the retina458582$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate3619,487$12,149
IlevroNepafenac19995$9,219
MoxifloxacinMoxifloxacin Hcl1392,622$3,082
Ketorolac TromethamineKetorolac Tromethamine1113,793$1,928
Atropine SulfateAtropine Sulfate391,750$1,798

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.14$6,707Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Philip Isaac Niles, MD?

Tedicare shows public-source Medicare data for Philip Isaac Niles, MD (NPI 1609136126), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Philip Isaac Niles, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Philip Isaac Niles, MD?

Philip Isaac Niles, MD is linked to OPHTHALMIC CONSULTANTS OF LONG ISLAND (billing NPI 1285675660) in the available physician profile data.

Does Philip Isaac Niles, MD have Open Payments data?

Philip Isaac Niles, MD has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.